Overview
Ebba Lindqvist practices in Stockholm, Sweden. Ms. Lindqvist is rated as a Distinguished expert by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Paraplegia, Adult Soft Tissue Sarcoma, and Mastectomy.
Her clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Monoclonal Gammopathy of Undetermined Significance (MGUS).
Locations
Stockholm, AB 11883, Sweden
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Experienced
- Adult Soft Tissue SarcomaMs. Lindqvist isExperienced. Learn about Adult Soft Tissue Sarcoma.
- MastectomyMs. Lindqvist isExperienced. Learn about Mastectomy.
- MelanomaMs. Lindqvist isExperienced. Learn about Melanoma.
- Multiple MyelomaMs. Lindqvist isExperienced. Learn about Multiple Myeloma.
- ParaplegiaMs. Lindqvist isExperienced. Learn about Paraplegia.